NMDS Group
Home
Guidelines
Clinical Trials
About us
News
Meetings
About NMDSG
Publications
Regional Coordinators
Members
Contact
Membership
For Patients
Links
Patient Information
Videos
Members
Search
Home
Clinical Trials
Closed Clinical Trials
Filters
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Closed Clinical Trials
Title
Hits
NMDSG07A. A multicentre phase II study of the efficacy and safety of lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q) or monosomy 5 (NMDSG07A). Published.
Hits: 1403
NMDSG08A. Clinical and biological evaluation of azacitidine in transfusion-dependent patients with low and intermediate-1 risk MDS, and low-risk CMML, who are either refractory to or not eligible for treatment with erythropoietin +/- G-CSF. Published.
Hits: 2106
NMDSG10A. A pilot phase I dose finding safety study of a Thrombopoietin-receptor agonist, Eltrombopag, in patients with Myelodysplastic syndrome treated with Azacitidine (NMDSG10A). Published.
Hits: 1232
NMDSG10B. A multicentre open randomized phase II study of the efficacy and safety of azacitidine alone or in combination with lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q). Closed.
Hits: 4087
Trials by Tag
MDS
4
Open for inclusion
2
Phase 2
2
Investigator Sponsored Trial
2
CMML
1
Closed
1
AML
1
News
NMDSG fall meeting 14-15 Nov 2019
NMDSG Spring meeting May 8th 2019
NMDSG meeting & MDSF symposium May 2019
Patient information
Danish
Myelodysplastisk syndrom
Finnish
Tietoa myelodysplastisesta syndroomasta
Icelandic
Myelodysplastic syndrome
Norwegian
Myelodysplastisk syndrom
Swedish
Myelodysplastiskt syndrom